MEND - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 88205738
Serial Number
88205738
Word Mark
MEND
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-06-08
Filing Date
2018-11-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-07-09
Law Office Assigned Location Code
S10
Employee Name
GALAN, MATTHEW
Statements
Goods and Services
Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of traumatic brain injury; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Bismuth preparations for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Vegan protein for use as a nutritional supplement in ready-to-drink beverages
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-12-14
Primary Code
005
Correspondences
Name
MEND NUTRITION INC.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration4503124
Trademark Events
Event DateEvent Description
2018-11-29NEW APPLICATION ENTERED IN TRAM
2018-12-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-02-22ASSIGNED TO EXAMINER
2019-02-25NON-FINAL ACTION WRITTEN
2019-02-25NON-FINAL ACTION E-MAILED
2019-02-25NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-04-24TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-05-06ASSIGNED TO LIE
2019-05-06ASSIGNED TO LIE
2019-05-06CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-05-06TEAS/EMAIL CORRESPONDENCE ENTERED
2019-05-31APPROVED FOR PUB - PRINCIPAL REGISTER
2019-06-19NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-07-09PUBLISHED FOR OPPOSITION
2019-07-09OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-09-03NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-06-08ABANDONMENT - NO USE STATEMENT FILED
2020-06-08ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED